IP Library › Granted Patent US 12,042,579
Granted Patent B2
US 12,042,579 · App. 17/017,346 · Granted Jul 23, 2024

Self-expanding stent and manufacturing method therefor

Inventors: Shuhei Matsushita (Hadano, JP); Kazuyoshi Tani (Kawasaki, JP); Atsunori Yoshida (Kanagawa, JP)
Assignee: TERUMO KABUSHIKI KAISHA
A61L31/041A61L31/148C08G63/912A61F2/89A61L2400/16C08G2230/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,042,579
App. No.
17/017,346
Granted
Jul 23, 2024
Kind
B2
Abstract

A self-expandable stent has sufficient radial force, has good bending properties, and recovers the shape for the diameter thereof to return from a diameter in a contracted state to a diameter before contraction around a body temperature (37° C.). The self-expandable stent includes a crosslinked polymer containing a constitutional unit (A) obtained from a monomer that constitutes a rigid biodegradable polymer when homopolymerized and a constitutional unit (B) obtained from a crosslinking agent, in which a content of the constitutional unit (B) is 15% by weight to 35% by weight with respect to a content of the constitutional unit (A).

Claims (33)

1. A self-expandable stent comprising a crosslinked polymer consisting of a constitutional unit (A) obtained from a monomer that constitutes a rigid biodegradable polymer when homopolymerized and a constitutional unit (B) obtained from a crosslinking agent,

wherein a content of the constitutional unit (B) is 15% by weight to 35% by weight with respect to a content of the constitutional unit (A),

wherein the crosslinking agent is a monomer having two or more polymerizable unsaturated bonds, wherein the crosslinking agent includes pentaerythritol tetraacrylate, dipentaerythritol penta/hexa-acrylate, or a combination thereof.

2. The self-expandable stent according to claim 1 ,

wherein a Young's modulus of the crosslinked polymer is 500 N/mm 2 or more and a recovery rate thereof after 10 seconds is 65% or more.

3. The self-expandable stent according to claim 1 ,

wherein a Martens hardness of the crosslinked polymer is 50 N/mm 2 or more in a case where a loading-unloading test is carried out using a nanoindenter.

4. The self-expandable stent according to claim 1 ,

wherein the crosslinked polymer is obtained by polymerizing the crosslinking agent with a polymer containing the constitutional unit (A) obtained from the monomer that constitutes the rigid biodegradable polymer when homopolymerized and,

an absolute value of a difference between a solubility parameter value of the crosslinking agent and a solubility parameter value of the monomer that constitutes the rigid biodegradable polymer when homopolymerized is 5 (J/cm 3 ) 1/2 or less.

5. The self-expandable stent according to claim 1 ,

wherein the monomer that constitutes the rigid biodegradable polymer when homopolymerized contains at least one of lactic acid and glycolic acid.

6. The self-expandable stent according to claim 1 ,

wherein the content of the constitutional unit (B) is 25% by weight to 35% by weight with respect to the content of the constitutional unit (A).

7. The self-expandable stent according to claim 1 ,

wherein the monomer that constitutes the rigid biodegradable polymer when homopolymerized includes lactic acid, glycolic acid, or a combination thereof.

8. The self-expandable stent according to claim 1 ,

wherein the monomer that constitutes the rigid biodegradable polymer when homopolymerized includes poly L-lactic acid.

9. A method for producing a self-expandable stent, the method comprising:

polymerizing a polymer consisting of a constitutional unit (A) obtained from a monomer that constitutes a rigid biodegradable polymer when homopolymerized and a constitutional unit (B) obtained from a crosslinking agent having a content of 15% by weight to 35% by weight with respect to a content of the constitutional unit (A) to obtain a crosslinked polymer, wherein the crosslinking agent is a monomer having two or more polymerizable unsaturated bonds, wherein the crosslinking agent includes pentaerythritol tetraacrylate, dipentaerythritol penta/hexa-acrylate, or a combination thereof; and

producing the stent using the crosslinked polymer.

10. The method for producing a self-expandable stent according to claim 9 ,

wherein a weight average molecular weight of the polymer is 100,000 to 1,000,000.

11. The method for producing a self-expandable stent according to claim 9 ,

wherein the polymer and the crosslinking agent are polymerized under irradiation with an ultraviolet ray.

12. The method for producing a self-expandable stent according to claim 9 ,

wherein the polymer containing the constitutional unit (A) and the crosslinking agent are polymerized in the presence of a photopolymerization initiator.

13. The method for producing a self-expandable stent according to claim 9 ,

wherein the monomer that constitutes the rigid biodegradable polymer when homopolymerized includes lactic acid, glycolic acid, or a combination thereof.

14. The method for producing a self-expandable stent according to claim 9 ,

wherein the monomer that constitutes the rigid biodegradable polymer when homopolymerized includes poly L-lactic acid.

15. The self-expandable stent according to claim 1 , wherein the crosslinking agent is pentaerythritol tetraacrylate.

16. The method for producing a self-expandable stent according to claim 9 , wherein the crosslinking agent is pentaerythritol tetraacrylate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2020
From: MATSUSHITA, SHUHEI; TANI, KAZUYOSHI; YOSHIDA, ATSUNORI
To: TERUMO KABUSHIKI KAISHA
Reel/Frame 053738/0511 →
Priority Claims (1)
JP 2018-048377 · Mar 15, 2018 · national
Continuity (2)
Continuation PCTJP2019002966 · Jan 29, 2019
Related Publication 20200405920A1 · Dec 31, 2020